May-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Market Insights Snapshot
In May 2026, SunMed’s mix tilted further toward inhalables, with Flower at 69.21% share (up 17.16% MoM and 4.38% YoY) and Pre-Roll at 23.32% share (up 18.48% MoM and 69.99% YoY), while Vapor Pens held 3.63% share (up 21.94% MoM but down 7.33% YoY). Concentrates accounted for 3.78% share (up 24.76% MoM yet down 24.69% YoY), and Edible remained a rounding error at 0.05% share despite a 66.55% MoM and 244.31% YoY jump. With an overall brand sales YoY change of 12.37% and a 15.92% YoY decline in average price, the pattern implies SunMed is leaning on volume growth in Flower and Pre-Roll to offset pricing compression and weakness in smaller format categories.
Holding rank 2 in Flower in Maryland during May 2026, combined with Pre-Roll’s 69.99% YoY surge and 18.48% MoM lift, indicates SunMed’s positioning is concentrated around value-forward inhalables where price elasticity is actionable; the 21.94% MoM uptick in Vapor Pens alongside a 7.33% YoY decline suggests selective promo or assortment moves are driving near-term trial rather than durable share. The 24.76% MoM bounce in Concentrates amid a 24.69% YoY contraction, together with Edible’s 0.05% share despite triple-digit growth, implies the brand’s near-term advantage lies in defending and expanding Flower-led baskets while treating non-core formats as opportunistic, supporting a strategy that prioritizes market depth in Maryland Flower over breadth across minor categories.
Competitive Landscape
SunMed sits at rank #2 in MD Flower in May 2026, down 1 place year over year from #1, after peaking at #1 in March 2026 and slipping from #1 three months ago; meanwhile, Fade Co. climbed from #3 to #1 with 65.9% YoY sales growth while RYTHM fell from #2 to #3 with a -9.1% YoY sales change, signaling competitive share rotation at the top. The contrast with Strane moving from #8 to #4 on 74.5% YoY growth and District Cannabis rising from #4 to #5 on 26.8% YoY growth indicates SunMed’s -1 rank delta coincides with faster upward mobility from adjacent rivals; the pattern implies SunMed’s trajectory is one of defending a top-two position amid accelerating challengers rather than reclaiming a stable #1 without a counter-move.

Notable Products
Sunshine #4 Pre-Roll 2-Pack (1g) delivered the headline movement in May 2026 with a +62.2% MoM surge into rank 8, while Snoop Dogg OG Pre-Roll 2-Pack (1g) slid -13.3% to rank 6, signaling a pivot within pre-rolls toward newer SKUs over legacy names. At the top, Sour Diesel Pre-Roll 2-Pack (1g) held rank 1 with +7.9% MoM and SDG OG Pre-Roll 2-Pack (1g) advanced +17.7% at rank 2, and six of the top ten were Pre-Roll SKUs, pointing to a format-led mix even as Flower like Sour Diesel (3.5g) climbed +32.8% at rank 3. Snoop Dogg (3.5g) gained +19.6% at rank 4 while Chem De La Chem Pre-Roll 2-Pack (1g) eased -6.3% at rank 5, and the broad pre-roll presence contrasts with concentrated Flower momentum where Chem de la Chem (3.5g) added +17.8% at rank 9. The pattern implies SunMed is consolidating around high-velocity pre-rolls while selectively scaling a few Flower flagships, a mix that prioritizes repeatable pack formats for volume with targeted premium Flower to anchor basket value around $388,401.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.







